VMI
RARX
VHCP Management II’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-677,164
| Closed | -$16M | – | 28 |
|
|
2019
Q3 | $16M | Hold |
677,164
| – | – | 6.1% | 7 |
|
|
2019
Q2 | $20.4M | Buy |
677,164
+44,684
| +7% | +$1.34M | 6.42% | 6 |
|
|
2019
Q1 | $14.2M | Hold |
632,480
| – | – | 4.15% | 9 |
|
|
2018
Q4 | $11.5M | Buy |
632,480
+87,868
| +16% | +$1.6M | 4.94% | 9 |
|
|
2018
Q3 | $9.85M | Hold |
544,612
| – | – | 2.63% | 11 |
|
|
2018
Q2 | $5.42M | Hold |
544,612
| – | – | 1.62% | 15 |
|
|
2018
Q1 | $2.89M | Hold |
544,612
| – | – | 0.7% | 16 |
|
|
2017
Q4 | $4.63M | Sell |
544,612
-225,159
| -29% | -$1.91M | 1.11% | 14 |
|
|
2017
Q3 | $11.2M | Hold |
769,771
| – | – | 3.11% | 11 |
|
|
2017
Q2 | $14.4M | Buy |
769,771
+44,742
| +6% | +$838K | 5.76% | 6 |
|
|
2017
Q1 | $15.4M | Buy |
725,029
+182,529
| +34% | +$3.89M | 6.32% | 6 |
|
|
2016
Q4 | $8.24M | Buy |
+542,500
| New | +$8.24M | 3.95% | 7 |
|